Cellectar Biosciences CLRB

$ 1.59 0.32%

Quarterly report 2024-Q3
added 11-18-2024

Cellectar Biosciences Balance Sheet 2011-2024 | CLRB

Annual Balance Sheet Cellectar Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-9.01 M	-19.3 M	-35.4 M	-57.2 M	-10.1 M	-13.3 M	-10 M	-11.4 M	-3.53 M	-8.97 M	-1.97 M	-4.22 M	-5.05 M
Long Term Debt	494 K	553 K	166 K	-	-	-	-	-	86.6 K	330 K	450 K	450 K	450 K
Long Term Debt Current	59 K	50.8 K	135 K	120 K	106 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	422 K	171 K	2.21 K	152 K	244 K	489 K	593 K	587 K	578 K
Total Current Liabilities	25.4 M	11.5 M	3.99 M	3.56 M	2.77 M	1.62 M	2.11 M	1.63 M	5.7 M	6.23 M	4.52 M	733 K	504 K
Total Liabilities	25.9 M	12.1 M	4.16 M	302 K	3.19 M	1.79 M	2.12 M	1.78 M	5.95 M	2.67 M	5.12 M	1.32 M	1.08 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-203 M	-160 M	-151 M	-	-112 M	-97.6 M	-84.3 M	-70.8 M	-64.6 M	-59.2 M	-51.1 M	-40.3 M	-31.5 M
Total Assets	12.1 M	21.6 M	37.2 M	58.7 M	12.3 M	15.1 M	12.9 M	15.3 M	7.6 M	13.4 M	6.82 M	11.5 M	10.6 M
Cash and Cash Equivalents	9.56 M	19.9 M	35.7 M	57.2 M	10.6 M	13.3 M	10 M	11.4 M	3.86 M	9.42 M	2.42 M	4.68 M	5.51 M
Book Value	-13.8 M	9.54 M	33 M	58.4 M	9.06 M	13.3 M	10.8 M	13.5 M	1.65 M	10.7 M	1.7 M	10.2 M	9.48 M
Total Shareholders Equity	-15.2 M	8.15 M	33 M	54.8 M	9.06 M	13.3 M	10.8 M	13.5 M	1.65 M	6.7 M	1.7 M	10.2 M	9.48 M

All numbers in USD currency

Quarterly Balance Sheet Cellectar Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	432 K	454 K	474 K	494 K	513 K	531 K	548 K	553 K	53.8 K	-	130 K	166 K	202 K	236 K	269 K	302 K	302 K	302 K	302 K	422 K	422 K	422 K	422 K	-	-	-	-	-	-	-	-	-	-	-	-	330 K	-	-	-	450 K	-	3.8 M	3.77 M	450 K	-	-	-	450 K	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	302 K	517 K	548 K	393 K	422 K	422 K	422 K	422 K	171 K	171 K	171 K	171 K	2.21 K	2.21 K	2.21 K	2.21 K	152 K	152 K	152 K	152 K	244 K	244 K	244 K	244 K	489 K	489 K	489 K	489 K	593 K	593 K	593 K	593 K	587 K	587 K	587 K	587 K	578 K	578 K	578 K	578 K
Total Liabilities	20.7 M	15.6 M	16.7 M	25.9 M	17 M	6.98 M	7.5 M	6.08 M	6.57 M	-	4.78 M	4.16 M	3.37 M	3.75 M	5.29 M	3.86 M	3.86 M	3.86 M	3.86 M	3.19 M	3.19 M	3.19 M	3.19 M	1.79 M	1.79 M	1.79 M	1.79 M	2.12 M	2.12 M	2.12 M	2.12 M	1.78 M	1.78 M	1.78 M	1.78 M	5.95 M	5.95 M	5.95 M	5.95 M	6.72 M	6.72 M	6.72 M	6.72 M	5.12 M	5.12 M	5.12 M	5.12 M	1.32 M	1.32 M	1.32 M	1.32 M	1.08 M	-	1.08 M	1.08 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-245 M	-230 M	-239 M	-203 M	-210 M	-196 M	-	-179 M	-172 M	-	-	-151 M	-145 M	-139 M	-133 M	-127 M	-127 M	-127 M	-127 M	-112 M	-112 M	-112 M	-112 M	-97.6 M	-97.6 M	-97.6 M	-97.6 M	-84.3 M	-84.3 M	-84.3 M	-84.3 M	-70.8 M	-70.8 M	-70.8 M	-70.8 M	-64.6 M	-64.6 M	-64.6 M	-64.6 M	-59.1 M	-59.1 M	-59.1 M	-59.1 M	-51.1 M	-51.1 M	-51.1 M	-	-	-	-	-	-	-	-	-
Total Assets	37.3 M	29.4 M	42.9 M	12.1 M	21.6 M	6.51 M	14.8 M	21.6 M	19.3 M	-	32 M	37.2 M	42 M	47.7 M	55.1 M	58.7 M	58.7 M	58.7 M	58.7 M	12.3 M	12.3 M	12.3 M	12.3 M	15.1 M	15.1 M	15.1 M	15.1 M	12.9 M	12.9 M	12.9 M	12.9 M	15.3 M	15.3 M	15.3 M	15.3 M	7.6 M	7.6 M	7.6 M	7.6 M	13.4 M	13.4 M	13.4 M	13.4 M	6.82 M	6.82 M	6.82 M	6.82 M	11.5 M	11.5 M	11.5 M	11.5 M	10.6 M	10.6 M	10.6 M	10.6 M
Cash and Cash Equivalents	34.3 M	25.9 M	40 M	9.56 M	19 M	5.15 M	12.7 M	19.9 M	17.8 M	24.8 M	30.6 M	35.7 M	40.3 M	46.8 M	53.6 M	57.2 M	57.2 M	57.2 M	57.2 M	10.6 M	10.6 M	10.6 M	10.6 M	13.3 M	13.3 M	13.3 M	13.3 M	10 M	10 M	10 M	10 M	11.4 M	11.4 M	11.4 M	11.4 M	3.91 M	3.86 M	3.86 M	3.86 M	9.42 M	9.42 M	9.42 M	9.42 M	2.42 M	2.42 M	2.42 M	2.42 M	4.68 M	4.68 M	4.68 M	4.68 M	5.51 M	5.51 M	5.51 M	5.51 M
Book Value	16.5 M	13.8 M	26.2 M	-13.8 M	4.57 M	-467 K	7.33 M	15.5 M	12.8 M	-	27.2 M	33 M	38.6 M	44 M	49.8 M	54.8 M	54.8 M	54.8 M	54.8 M	9.06 M	9.06 M	9.06 M	9.06 M	13.3 M	13.3 M	13.3 M	13.3 M	10.8 M	10.8 M	10.8 M	10.8 M	13.5 M	13.5 M	13.5 M	13.5 M	1.65 M	1.65 M	1.65 M	1.65 M	6.7 M	6.7 M	6.7 M	6.7 M	1.7 M	1.7 M	1.7 M	1.7 M	10.2 M	10.2 M	10.2 M	10.2 M	9.48 M	10.6 M	9.48 M	9.48 M
Total Shareholders Equity	15.2 M	12.4 M	26.2 M	-15.2 M	-28 M	-8.39 M	7.33 M	15.5 M	12.8 M	20.2 M	27.2 M	33 M	38.6 M	44 M	49.8 M	54.8 M	54.8 M	54.8 M	54.8 M	9.06 M	9.06 M	9.06 M	9.06 M	13.3 M	13.3 M	13.3 M	13.3 M	10.8 M	10.8 M	10.8 M	10.8 M	13.5 M	13.5 M	13.5 M	13.5 M	1.65 M	1.65 M	1.65 M	1.65 M	6.7 M	6.7 M	6.7 M	6.7 M	1.7 M	1.7 M	1.7 M	1.7 M	10.2 M	10.2 M	10.2 M	10.2 M	9.48 M	9.48 M	9.48 M	9.48 M

All numbers in USD currency